GBM exploits multiple heterogeneous mechanisms of immune suppression, such as elaborated TGF-β, IL-10, and galectin 3, that exert profound effects on T cells; this redundancy of immunosuppressive mechanisms likely contributes to the lack of adenosine blockage reversal. This evidence concerns the gene TGFB1 and glioblastoma.